Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Yoon’s jailed mother-in-law excluded from latest parole list

    Yoon’s jailed mother-in-law excluded from latest parole list
  2. 2

    [Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'

    [Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
  3. 3

    Korea’s homegrown nanosatellite successfully launches into space

    Korea’s homegrown nanosatellite successfully launches into space
  4. 4

    [Pressure points] Leggings in public: Fashion statement or social faux pas?

    [Pressure points] Leggings in public: Fashion statement or social faux pas?
  5. 5

    Nicaragua shuts down Seoul embassy

    Nicaragua shuts down Seoul embassy
  1. 6

    Rocket engine expert, ex-NASA exec to lead Korea's new space agency

    Rocket engine expert, ex-NASA exec to lead Korea's new space agency
  2. 7

    SK hynix pledges W20tr to ramp up DRAM production at home

    SK hynix pledges W20tr to ramp up DRAM production at home
  3. 8

    SNU profs to suspend treatment for one day

    SNU profs to suspend treatment for one day
  4. 9

    Hybe's multilabel system tested amid conflict with Ador

    Hybe's multilabel system tested amid conflict with Ador
  5. 10

    Over-50s, men, single-person households take up majority of those filing for bankruptcy

    Over-50s, men, single-person households take up majority of those filing for bankruptcy
피터빈트

Medipost gets US patent for cartilage treatment technology

By Korea Herald

Published : June 30, 2016 - 10:43

    • Link copied

[THE INVESTOR] Korean pharmaceutical firm Medipost has been granted a US patent for its cell therapeutic technology used in its osteoarthritis treatment solution Cartistem, the company’s spokesperson said on June 29. 


The mechanism alleviates knee cartilage pains with mesenchymal stem cells extracted from allogeneic umbilical cord blood. 

Medipost's osteoarthritis treatment solution Cartistem Medipost's osteoarthritis treatment solution Cartistem

Medipost already holds US patents for its two other cell-based technologies that act as bases for treatment of Alzheimer’s disease and Bronchopulmonary dysplasia in premature infants.

By Jung Min-kyung (mkj1105@heraldcorp.com)

More from Headlines